News

The Dose Podcast: Ep 1 "TB and the AMR Crisis"

13 Aug 2018
by Working Group
WGND Podcast Series TB R&D AMR Antibiotic R&D
podcast TB TB R&D AMR Antibiotic R&D Global Health Epidemic

The Stop TB Partnership's Working Group on New Drugs presents a new podcast series entitled "The Dose". In this series, the WGND will bring together drug developers, researchers in the TB R&D field, TB patients, global health experts, and donors to discuss, prioritize, and develop strategies to help meet the most pressing needs faced by the TB drug R&D community.

Episode 1 "TB and the AMR Crisis"

Episode 1 will focus on TB and antimicrobial resistance (AMR). Today, AMR is one of the defining health issues of our time. Drug resistant tuberculosis is the cornerstone of the global AMR challenge, which accounts for a quarter of AMR fatalities per year. This podcast will highlight the opportunities, and challenges to advancing action on AMR and tuberculosis.

Moderator: Shobha Shukla, Citizen News Service

Speaker: Mario Raviglione, University of Milan (Previously Global TB Programme, WHO) 

Speaker: Manica Balasegaram, Global Antibiotic Research and Develpment Partnership (GARDP)

 

Listen on Soundcloud: https://soundcloud.com/user-87209407/the-dose-podcast-july-2018 

More News
22 Jul 2024

With NIH Funding, A New Consortium Aims to Improve TB Treatment

The National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) has issued a $30.8 million grant to the Preclinical Design and Clinical Translation of TB Regimens (PreDiCTR) consortium , a new consortium co-led by investigators from Weill Cornell Medicine; the...
27 Jun 2024

WHO Released Its Updated Bacterial Priority Pathogens List

On May 17, the World Health Organization (WHO) released its updated  Bacterial Priority Pathogens List (BPPL) 2024 and for the first time in its history it included a drug resistant strain of Mycobacterium tuberculosis. Along with three other new families of antibiotic-resistant bacterial pathogens...
19 Mar 2024

Most Robust TB Drug Pipeline in History

For World TB Day 2024, the WGND is spotlighting a monumental achievement in TB drug research and development: the Global TB Drug Pipeline has never been bigger than it is today. The number of drug candidates being clinically evaluated for use in the treatment of adult pulmonary TB has surpassed...